Walgreens Boots Alliance reached a $683 million settlement with Florida to resolve claims that the pharmacy chain exacerbated an opioid epidemic in the state.

Teva Pharmaceutical Industries believes the company would have to pay around $2.6 billion in cash and medicine to settle thousands of lawsuits alleging the world’s largest generic firm and other drug manufacturers fueled the U.S. opioid epidemic.

Walgreens Boots Alliance Inc. supplied billions of opioid pills to drug addicts and criminals, contributing to an addiction epidemic in Florida, a lawyer for the state said on April 11 as a civil trial against the pharmacy chain got underway.

Florida reached more than $878 million in settlements with CVS Health Corp. and three drug companies to resolve claims and avert a trial in April over their roles in fueling an opioid epidemic in the third most populous U.S. state.

As Russia continues to bombard cities across Ukraine in artillery strikes, thousands of people have huddled in underground metro stations and bunkers to escape the devastation of those attacks. But another type of attack could result from this – a new outbreak of COVID-19 infection. 

Florida’s top health official said on March 7 the state would recommend against the COVID-19 vaccine for healthy children, breaking with guidance from the U.S. Centers for Disease Control and Prevention.

Endo International agreed to pay up to $65 million to resolve claims by the state of Florida and local governments that the drugmaker helped fuel the U.S. opioid epidemic.

U.S. President Joe Biden on Sept. 16 directed his ire at the governors of Florida and Texas, accusing the Republican leaders of “doing everything they can to undermine the life-saving requirements” he proposed to counter the spread of Covid-19.

In a scene replayed across the United States, angry parents and activists streamed into a meeting of the Florida’s Lake County school board on Sept. 2 where it considered whether to mandate mask-wearing for students and staff due to Covid.

Biogen Inc. is providing the company’s controversial and expensive new Alzheimer’s drug free of charge for some patients amid slow claim reviews by Medicare, according to sources familiar with the situation, including a doctor treating patients with the drug.